PRKDC and hepatocellular carcinoma: The results showed that the stable knockout of SETDB1 in Hepa1-6 cells significantly reduced the size of HCC tumors formed in the FAH/Prkdc/IL2RG mutation mice compared with the non-target sgRNA control (Figure 3G).